- HEALTH INFORMATION
- GET SUPPORT
- NEWS & VIEWS
- GET INVOLVED
- CARE PROVIDERS
FEBRUARY 06, 2004 - The Preeclampsia Foundation today issued a statement of cautious optimism about the new study to be published in next week's New England Journal of Medicine, indicating a unique protein marker is sharply elevated five weeks prior to the onset of preeclampsia.
Anne Garrett, Executive Director of the Preeclampsia Foundation, the nation's only patient advocacy organization dedicated to hypertensive disorders of pregnancy, said, "The study shows great promise that a definitive diagnostic tool could be developed to identify which pregnant women will develop this potentially life-threatening complication. While we are extremely excited that the cause of preeclampsia may have been discovered, a fact that has eluded medical experts for hundreds of years, we are especially hopeful that this may herald an increase in awareness and research funding for a cure. It is extremely important that science, academia and industry partner their resources to advance a proven therapy. The mortality rate from preeclampsia and related conditions for women and their babies is unacceptable.
2016 ACOG-CDC Meeting on Maternal Safety and Mortality
May 15, 2016
Healthy Start Coalition of Miami-Dade Prematurity Symposium
May 20, 2016
11th Annual Texas Conference on Health Disparities
Ft. Worth, TX
June 9-10, 2016